Effect of Normalization of Fasting Glucose by Intensified Insulin Therapy on the Incidence of Restenosis After Peripheral Angioplasty in Patients With Type 2 Diabetes.

Trial Profile

Effect of Normalization of Fasting Glucose by Intensified Insulin Therapy on the Incidence of Restenosis After Peripheral Angioplasty in Patients With Type 2 Diabetes.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2013

At a glance

  • Drugs Insulin glargine (Primary) ; Biguanides; Insulin; Meglitinide; Sulfonylureas
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms LIMBISCH
  • Most Recent Events

    • 01 May 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 30 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top